Skip to main content
Premium Trial:

Request an Annual Quote

Sensigen Lands Loan from Michigan Economic Development Group

NEW YORK (GenomeWeb News) – Molecular diagnostics company Sensigen said today it plans to use a loan at 1 percent interest from the Michigan Economic Development Corporation to expand its operations in Ann Arbor.
 
The company, which is developing diagnostic tests for human papillomavirus, chronic kidney disease, lupus, and other diseases, will use the money from the loan to hire workers that have been displaced by the closing of a Pfizer facility in Michigan.
 
The company’s molecular diagnostics technology, which combines mass spectrometry and PCR, was developed by University of Michigan researcher David Kurnit.
 
MEDC is a partnership between the State of Michigan and local communities that promote economic growth and development strategies.
 
Further terms of the loan agreement were not released.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.